Build Your Comparison

Side-by-side financial analysis
ACOG logo
ACOG
AVXL logo
AVXL
Try popular comparisons:

Stock Comparison

ACOG vs AVXL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ACOG
Alpha Cognition Inc. Common Stock

Financial - Conglomerates

Financial ServicesNASDAQ • CA
Market Cap$98M
5Y Perf.-4.8%
AVXL
Anavex Life Sciences Corp.

Biotechnology

HealthcareNASDAQ • US
Market Cap$232M
5Y Perf.-73.6%

ACOG vs AVXL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ACOG logoACOG
AVXL logoAVXL
IndustryFinancial - ConglomeratesBiotechnology
Market Cap$98M$232M
Revenue (TTM)$11M
Net Income (TTM)$-25M$-40M
Gross Margin86.4%
Operating Margin-250.1%
Total Debt$0.00$0.00
Cash & Equiv.$66M$103M

ACOG vs AVXLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ACOG
AVXL
StockNov 24Jun 26Return
Alpha Cognition Inc… (ACOG)10095.2-4.8%
Anavex Life Science… (AVXL)10026.4-73.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ACOG vs AVXL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AVXL leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Alpha Cognition Inc. Common Stock is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇AVXL emerged as the overall leader. Track its performance:
ACOG
Alpha Cognition Inc. Common Stock
The Banking Pick

ACOG is the clearest fit if your priority is income & stability and growth exposure.

  • beta 1.29
  • EPS growth 42.1%
  • -11.3% 10Y total return vs AVXL's -38.3%
Best for: income & stability and growth exposure
AVXL
Anavex Life Sciences Corp.
The Growth Leader

AVXL carries the broadest edge in this set and is the clearest fit for growth and quality.

  • -34.9% revenue growth vs ACOG's -116.5%
  • 4.5% margin vs ACOG's -232.2%
  • -35.0% ROA vs ACOG's -41.8%
Best for: growth and quality
See the full category breakdown
CategoryWinnerWhy
GrowthAVXL logoAVXL-34.9% revenue growth vs ACOG's -116.5%
Quality / MarginsAVXL logoAVXL4.5% margin vs ACOG's -232.2%
Stability / SafetyACOG logoACOGBeta 1.29 vs AVXL's 1.77
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)ACOG logoACOG-34.4% vs AVXL's -69.6%
Efficiency (ROA)AVXL logoAVXL-35.0% ROA vs ACOG's -41.8%

ACOG vs AVXL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ACOGAlpha Cognition Inc. Common Stock
FY 2025
Service
100.0%$433,221
AVXLAnavex Life Sciences Corp.

Segment breakdown not available.

ACOG vs AVXL — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACOGLAGGINGAVXL

Income & Cash Flow (Last 12 Months)

AVXL leads this category, winning 1 of 1 comparable metric.
MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
RevenueTrailing 12 months$11M
EBITDAEarnings before interest/tax-$27M-$39M
Net IncomeAfter-tax profit-$25M-$40M
Free Cash FlowCash after capex-$30M-$34M
Gross MarginGross profit ÷ Revenue+86.4%
Operating MarginEBIT ÷ Revenue-2.5%
Net MarginNet income ÷ Revenue-2.3%
FCF MarginFCF ÷ Revenue-2.8%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-146.2%+54.4%
AVXL leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

ACOG leads this category, winning 2 of 2 comparable metrics.
MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
Market CapShares × price$98M$232M
Enterprise ValueMkt cap + debt − cash$32M$129M
Trailing P/EPrice ÷ TTM EPS-5.38x-4.63x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue9.57x
Price / BookPrice ÷ Book value/share1.78x2.25x
Price / FCFMarket cap ÷ FCF
ACOG leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

AVXL leads this category, winning 3 of 5 comparable metrics.

AVXL delivers a -38.8% return on equity — every $100 of shareholder capital generates $-39 in annual profit, vs $-54 for ACOG. On the Piotroski fundamental quality scale (0–9), ACOG scores 4/9 vs AVXL's 2/9, reflecting mixed financial health.

MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
ROE (TTM)Return on equity-54.1%-38.8%
ROA (TTM)Return on assets-41.8%-35.0%
ROICReturn on invested capital-32.4%
ROCEReturn on capital employed-38.4%-47.8%
Piotroski ScoreFundamental quality 0–942
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash-$66M-$103M
Cash & Equiv.Liquid assets$66M$103M
Total DebtShort + long-term debt$0$0
Interest CoverageEBIT ÷ Interest expense
AVXL leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

ACOG leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in ACOG five years ago would be worth $8,873 today (with dividends reinvested), compared to $1,191 for AVXL. Over the past 12 months, ACOG leads with a -34.4% total return vs AVXL's -69.6%. The 3-year compound annual growth rate (CAGR) favors ACOG at -3.9% vs AVXL's -33.9% — a key indicator of consistent wealth creation.

MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
YTD ReturnYear-to-date-3.1%-32.1%
1-Year ReturnPast 12 months-34.4%-69.6%
3-Year ReturnCumulative with dividends-11.3%-71.1%
5-Year ReturnCumulative with dividends-11.3%-88.1%
10-Year ReturnCumulative with dividends-11.3%-38.3%
CAGR (3Y)Annualised 3-year return-3.9%-33.9%
ACOG leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

ACOG leads this category, winning 2 of 2 comparable metrics.

ACOG is the less volatile stock with a 1.29 beta — it tends to amplify market swings less than AVXL's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACOG currently trades 54.6% from its 52-week high vs AVXL's 17.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
Beta (5Y)Sensitivity to S&P 5001.29x1.77x
52-Week HighHighest price in past year$11.54$13.99
52-Week LowLowest price in past year$4.50$2.41
% of 52W HighCurrent price vs 52-week peak+54.6%+17.9%
RSI (14)Momentum oscillator 0–10050.936.8
Avg Volume (50D)Average daily shares traded42K1.0M
ACOG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ACOG as "Buy" and AVXL as "Buy". Consensus price targets imply 340.0% upside for AVXL (target: $11) vs 122.2% for ACOG (target: $14).

MetricACOG logoACOGAlpha Cognition I…AVXL logoAVXLAnavex Life Scien…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$14.00$11.00
# AnalystsCovering analysts113
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ACOG leads in 3 of 6 categories (Valuation Metrics, Total Returns). AVXL leads in 2 (Income & Cash Flow, Profitability & Efficiency).

Best OverallAlpha Cognition Inc. Common… (ACOG)Leads 3 of 6 categories
Loading custom metrics...

ACOG vs AVXL: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ACOG or AVXL a better buy right now?

Analysts rate Alpha Cognition Inc.

Common Stock (ACOG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ACOG or AVXL?

Over the past 5 years, Alpha Cognition Inc.

Common Stock (ACOG) delivered a total return of -11. 3%, compared to -88. 1% for Anavex Life Sciences Corp. (AVXL). Over 10 years, the gap is even starker: ACOG returned -11. 3% versus AVXL's -38. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ACOG or AVXL?

By beta (market sensitivity over 5 years), Alpha Cognition Inc.

Common Stock (ACOG) is the lower-risk stock at 1. 29β versus Anavex Life Sciences Corp. 's 1. 77β — meaning AVXL is approximately 38% more volatile than ACOG relative to the S&P 500.

04

Which is growing faster — ACOG or AVXL?

On earnings-per-share growth, the picture is similar: Alpha Cognition Inc.

Common Stock grew EPS 42. 1% year-over-year, compared to -3. 8% for Anavex Life Sciences Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ACOG or AVXL?

Anavex Life Sciences Corp.

(AVXL) is the more profitable company, earning 0. 0% net margin versus -202. 2% for Alpha Cognition Inc. Common Stock — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVXL leads at 0. 0% versus -221. 7% for ACOG. At the gross margin level — before operating expenses — ACOG leads at 81. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ACOG or AVXL?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ACOG or AVXL better for a retirement portfolio?

For long-horizon retirement investors, Alpha Cognition Inc.

Common Stock (ACOG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 29)). Anavex Life Sciences Corp. (AVXL) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACOG: -11. 3%, AVXL: -38. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ACOG and AVXL?

These companies operate in different sectors (ACOG (Financial Services) and AVXL (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.